Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety.

Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety.

<h4>Background</h4>Lisinopril and losartan manufacturer labels recommend twice-daily dosing (BID) if once-daily (QDay) is insufficient to lower blood pressure (BP).<h4>Methods and results</h4>Retrospective cohort study of patients taking QDay lisinopril and losartan who exper...

Full description

Saved in:
Bibliographic Details
Main Authors: Catherine G Derington, Jordan B King, Thomas Delate, Sheila R Botts, Miranda Kroehl, David P Kao, Katy E Trinkley
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0243371&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items